Beijing Biostar Pharmaceuticals Co., Ltd.

HK$3.50As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2563Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 2Y CAGR (58.61%)
Div yield —
ROE (15.00%)
Biotechnology
Beta (5Y) (0.30)
PE TTM —
TSR TTM 4.48%
Mkt cap HK$1.364B
ROIC (8.84%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.38
25.26%
(1.01%)
Hold 8|11|7|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.04
0.04
0.04
8.53%
7.28%
0.06%
10.29%
Revenue¥M
159.1
168.4
172.6
176.4
4.74%
5.34%
8.03%
10.01%
Peers (US$173.9M)
Cap (US$)
PE
170.4M
—
168.3M
—
171.1M
—
Capital
TTM
5Y
10Y
Leveragex
0.745
0.647
0.645
EBIT/Intx
0.219
0.264
0.256
Own earn%
80.25
41.87
44.81
Sh yield%
47.48
27.33
25.43
Owners
Insiders/Inst%
13.48
68.92
Short interest%
2.76
SBC / revenue%
2.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
19–23
$1 testx
0.1
Incr. ROIC%
2